A. Azizi, A. Kumar, F. Diaz-mitoma, and J. Mestecky, Enhancing oral vaccine potency by targeting intestinal M cells, PLoS Pathogens, vol.6, 2010.

M. Bankvall, M. Jontell, A. Wold, and S. Ostman, Tissue-specific differences in immune cell subsets located in the naso-oropharyngeal-associated lymphoid tissues, Scand. J. Immunol, vol.87, pp.15-27, 2018.

S. Batzri and E. D. Korn, Single bilayer liposomes prepared without sonication, Biochim. Biophys. Acta, vol.298, pp.1015-1019, 1973.

B. Bernocchi, R. Carpentier, I. Lantier, C. Ducournau, I. Dimier-poisson et al., Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles, J. Control. Release, vol.232, pp.42-50, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01595080

B. Bernocchi, R. Carpentier, and D. Betbeder, Nasal nanovaccines, Int. J. Pharm, vol.530, pp.128-138, 2017.

P. N. Boyaka, Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems, J. Immunol, vol.199, pp.9-16, 2017.

R. Carpentier, A. Platel, N. Salah, F. Nesslany, and D. Betbeder, Porous maltodextrinbased nanoparticles: a safe delivery system for nasal vaccines, J. Nanomater, 2018.

I. J. Castellanos and K. Griebenow, Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement, Pharm. Res, vol.20, pp.1873-1880, 2003.

J. Chang, Y. Jallouli, M. Kroubi, X. B. Yuan, W. Feng et al., Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier, Int. J. Pharm, vol.379, pp.285-292, 2009.

C. Clawson, C. T. Huang, D. Futalan, D. M. Seible, R. Saenz et al., Delivery of a peptide via poly(D, L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cellstimulatory capacity, Nanomed. Nanotechnol. Biol. Med, vol.6, pp.651-661, 2010.

J. P. Colletier, B. Chaize, M. Winterhalter, and D. Fournier, Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer, BMC Biotechnol, vol.2, p.9, 2002.

N. Csaba, M. Garcia-fuentes, and M. J. Alonso, Nanoparticles for nasal vaccination, Adv. Drug Deliv. Rev, vol.61, pp.140-157, 2009.

F. Danhier, E. Ansorena, J. M. Silva, R. Coco, A. Le-breton et al., PLGA-based nanoparticles: an overview of biomedical applications, J. Control. Release, vol.161, pp.505-522, 2012.

D. Serrano, L. O. Burkhart, and D. J. , Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines, J. Nanobiotechnol, vol.15, p.83, 2017.

I. Dimier-poisson, R. Carpentier, T. T. N'guyen, F. Dahmani, C. Ducournau et al., Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection, Biomaterials, vol.50, pp.164-175, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01190168

M. Diwan, P. Elamanchili, H. Lane, A. Gainer, and J. Samuel, Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses, J. Drug Target, vol.11, pp.495-507, 2003.

C. Dombu, R. Carpentier, and D. Betbeder, Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells, Biomaterials, vol.33, pp.9117-9126, 2012.

C. Ducournau, T. T. Nguyen, R. Carpentier, I. Lantier, S. Germon et al., Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice, Future Microbiol, vol.12, pp.393-405, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01608412

Y. Fujkuyama, D. Tokuhara, K. Kataoka, R. S. Gilbert, J. R. Mcghee et al., Novel vaccine development strategies for inducing mucosal immunity, Expert Rev. Vac, vol.11, pp.367-379, 2012.

K. Gradauer, C. Vonach, G. Leitinger, D. Kolb, E. Frohlich et al., Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties, Int. J. Nanomed, vol.7, pp.2523-2534, 2012.

Y. Jallouli, A. Paillard, J. Chang, E. Sevin, and D. Betbeder, Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro, Int. J. Pharm, vol.344, pp.103-109, 2007.

S. Juliusson, C. Bachert, H. Klementsson, G. Karlsson, and U. Pipkorn, Macrophages on the nasal mucosal surface in provoked and naturally occurring allergic rhinitis, Acta Otolaryngol, vol.111, pp.946-953, 1991.

K. Kurakula, A. A. Hamers, P. Van-loenen, and C. J. De-vries, 6-Mercaptopurine reduces cytokine and Muc5ac expression involving inhibition of NFkappaB activation in airway epithelial cells, Respir. Res, vol.16, p.73, 2015.

L. Broc-ryckewaert, D. Carpentier, R. Lipka, E. Daher, S. Vaccher et al., Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells, Int. J. Pharm, vol.454, pp.712-719, 2013.

M. Q. Le, R. Carpentier, I. Lantier, C. Ducournau, I. Dimier-poisson et al., Residence time and uptake of porous and cationic maltodextrin-based nanoparticles in the nasal mucosa: comparison with anionic and cationic nanoparticles, Int. J. Pharm, vol.550, pp.316-324, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02628930

Y. R. Lee, Y. H. Lee, S. A. Im, K. Kim, and C. K. Lee, Formulation and characterization of antigen-loaded PLGA nanoparticles for efficient cross-priming of the antigen, Immune Netw, vol.11, pp.163-168, 2011.

N. Marasini, M. Skwarczynski, and I. Toth, Intranasal delivery of nanoparticle-based vaccines, Therap. Deliv, vol.8, pp.151-167, 2017.

M. Snehalatha, K. V. Saha, and R. , Etoposide-loaded PLGA and PCL nanoparticles I: preparation and effect of formulation variables, Drug Deliv, vol.15, pp.267-275, 2008.

P. L. Ogra, H. Faden, and R. C. Welliver, Vaccination strategies for mucosal immune responses, Clin. Microbiol. Rev, vol.14, pp.430-445, 2001.

M. Q. Lê, International Journal of Pharmaceutics: X, vol.1, p.100001, 2019.

N. Oh and J. H. Park, Endocytosis and exocytosis of nanoparticles in mammalian cells, Int. J. Nanomed, vol.9, pp.51-63, 2014.

A. Pachioni-vasconcelos-jde, A. M. Lopes, A. C. Apolinario, J. K. Valenzuela-oses, J. S. Costa et al., Nanostructures for protein drug delivery, Biomater. Sci, vol.4, pp.205-218, 2016.

A. Paillard, C. Passirani, P. Saulnier, M. Kroubi, E. Garcion et al., Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers, Pharm. Res, vol.27, pp.126-133, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00491864

Y. P. Patil and S. Jadhav, Novel methods for liposome preparation, Chem. Phys. Lipids, vol.177, pp.8-18, 2014.

S. Prasad, V. Cody, J. K. Saucier-sawyer, W. M. Saltzman, C. T. Sasaki et al., Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy, Nanomed. Nanotechnol. Biol. Med, vol.7, pp.1-10, 2011.

A. Rivera, M. C. Siracusa, G. S. Yap, and W. C. Gause, Innate cell communication kickstarts pathogen-specific immunity, Nat. Immunol, vol.17, pp.356-363, 2016.

S. Ruiz, C. Beauvillain, M. N. Mevelec, P. Roingeard, P. Breton et al., A novel CD4-CD8alpha+CD205+CD11b-murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis, Cell. Microbiol, vol.7, pp.1659-1671, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02680845

V. Sanna, A. M. Roggio, S. Siliani, M. Piccinini, S. Marceddu et al., Development of novel cationic chitosan-and anionic alginate-coated poly(D, Llactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol, Int. J. Nanomed, vol.7, pp.5501-5516, 2012.

C. M. Solbrig, J. K. Saucier-sawyer, V. Cody, W. M. Saltzman, and D. J. Hanlon, Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells, Mol. Pharm, vol.4, pp.47-57, 2007.

C. Thomas, A. Rawat, L. Hope-weeks, and F. Ahsan, Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine, Mol. Pharm, vol.8, pp.405-415, 2011.

V. P. Torchilin, Recent advances with liposomes as pharmaceutical carriers, Nat. Rev. Drug Discov, vol.4, pp.145-160, 2005.

M. Van-de-weert, W. E. Hennink, and W. Jiskoot, Protein instability in poly(lactic-coglycolic acid) microparticles, Pharm. Res, vol.17, pp.1159-1167, 2000.

D. S. Watson, A. N. Endsley, and L. Huang, Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens, Vaccine, vol.30, pp.2256-2272, 2012.

M. Weitnauer, V. Mijosek, and A. H. Dalpke, Control of local immunity by airway epithelial cells, Mucosal Immunol, vol.9, pp.287-298, 2016.

X. Xu, M. A. Khan, and D. J. Burgess, A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment, Int. J. Pharm, vol.419, pp.52-59, 2011.

Y. W. Yang and W. H. Luo, Recruitment of bone marrow CD11b(+)Gr-1(+) cells by polymeric nanoparticles for antigen cross-presentation, Sci. Rep, vol.7, p.44691, 2017.

M. Zaman, S. Chandrudu, and I. Toth, Strategies for intranasal delivery of vaccines, Drug Deliv. Transl. Res, vol.3, pp.100-109, 2013.

L. Zhao, A. Seth, N. Wibowo, C. X. Zhao, N. Mitter et al., Nanoparticle vaccines, Vaccine, vol.32, pp.327-337, 2014.

M. Q. Lê, International Journal of Pharmaceutics: X, vol.1, p.100001, 2019.